Join to View Full Profile
1500 East Medical Center DrUniversity Hospital - Im Nephrology InpatientAnn Arbor, MI 48109
Phone+1 734-888-2871
Dr. Shayman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 1985 - 1985- Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 1983 - 1984
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1980 - 1983
- Washington University in St. Louis School of MedicineClass of 1980
Certifications & Licensure
MI State Medical License 1986 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1994
- Fellow (ASNF) American Society of Nephrology
Publications & Presentations
PubMed
- Heat shock protein 70s are modifiers of endothelial function in Fabry disease.Rakesh Verma, Audrey Cleuren, Vania Hinkovska-Galcheva, Ilka Decker, Robert Kelly
Kidney International. 2026-04-01 - Interaction Proteomics of Polycystins 1 and 2 Reveal a Novel Role for the BLOC-1/BORC Lysosomal Positioning Complex.Fatima Lukmani, Jonathan M Shillingford, Mackenzie Brauer, Dhairya Pancholi, Jonathan St- Germain
Molecular & Cellular Proteomics. 2025-11-01 - 2 citationsDegradation of oxidized phospholipids by lysosomal phospholipase A2 regulates pulmonary fibrosis.Doyun Kwak, Song Ling, Natalya Subbotina, James A Shayman, Tomas H Sisson
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2025-08-01
Press Mentions
Protalix’s Phase III Asset for Fabry Could Struggle to Demonstrate Superiority over Fabrazyme but Immunogenicity Benefits Support Regulatory Chances, Experts SayFebruary 5th, 2021
Sanofi Pivotal Trial to Target Driver of Cyst Growth in PKDNovember 12th, 2018
Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis from the HALT-PKD TrialsJanuary 4th, 2018
Grant Support
- Lysosomal Phospholipase A2 In Autoimmune DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2012
- The Pharmacological Treatment Of Fabry DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
- The Pharmacologic Treatment Of Fabry DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2008
- Glycosphingolipids In Diabetes MellitusNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1999
- Glycosphingolipid And Renal CarcinomaNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1997
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
